A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia. (Record no. 17016103)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02174 a2200637 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515065104.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200708s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0920-9964 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.schres.2007.03.011 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | George, Mark S |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20070830 |
245 00 - TITLE STATEMENT | |
Title | A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Schizophrenia research |
Date of publication, distribution, etc. | Jul 2007 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 42-50 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Randomized Controlled Trial |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antipsychotic Agents |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Brain |
General subdivision | blood supply |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cross-Over Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dopamine Agonists |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dose-Response Relationship, Drug |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Image Processing, Computer-Assisted |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Injections, Subcutaneous |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Magnetic Resonance Imaging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Memory, Short-Term |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neuropsychological Tests |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Oxygen |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phenanthridines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pilot Projects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Psychiatric Status Rating Scales |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptors, Dopamine D1 |
General subdivision | agonists |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Regional Blood Flow |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Schizophrenia |
General subdivision | diagnosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Molnar, Christine E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Grenesko, Emily L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Anderson, Berry |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mu, Qiwen |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Johnson, Kevin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nahas, Ziad |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Knable, Michael |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fernandes, Prabhavathi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Juncos, Jorge |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Huang, Xuemei |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nichols, David E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mailman, Richard B |
773 0# - HOST ITEM ENTRY | |
Title | Schizophrenia research |
Related parts | vol. 93 |
-- | no. 1-3 |
-- | p. 42-50 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.schres.2007.03.011">https://doi.org/10.1016/j.schres.2007.03.011</a> |
Public note | Available from publisher's website |
No items available.